DiaMedica Therapeutics, Inc. (DMAC)
8.42
-0.21
(-2.43%)
USD |
NASDAQ |
Oct 23, 10:26
DiaMedica Therapeutics Price : 8.42 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 22, 2026 | 8.70 | 8.946 | 8.51 | 8.63 | 87988.00 |
| Oct 21, 2026 | 8.72 | 8.95 | 8.59 | 8.69 | 155378.0 |
| Oct 20, 2026 | 7.88 | 8.87 | 7.88 | 8.67 | 168169.0 |
| Oct 19, 2026 | 7.78 | 7.99 | 7.60 | 7.87 | 188583.0 |
| Oct 16, 2026 | 8.04 | 8.10 | 7.53 | 7.57 | 260779.0 |
| Oct 15, 2026 | 7.82 | 8.24 | 7.66 | 8.04 | 303895.0 |
| Oct 14, 2026 | 7.68 | 8.02 | 7.61 | 7.66 | 286962.0 |
| Oct 13, 2026 | 8.21 | 8.21 | 7.72 | 7.82 | 256052.0 |
| Oct 12, 2026 | 8.26 | 8.335 | 7.945 | 8.20 | 185593.0 |
| Oct 09, 2026 | 8.00 | 8.450 | 8.00 | 8.33 | 170152.0 |
| Oct 08, 2026 | 7.92 | 8.06 | 7.66 | 8.01 | 240269.0 |
| Oct 07, 2026 | 8.01 | 8.415 | 7.95 | 7.99 | 221231.0 |
| Oct 06, 2026 | 8.50 | 8.61 | 8.05 | 8.13 | 242316.0 |
| Oct 05, 2026 | 8.23 | 8.63 | 8.19 | 8.42 | 231379.0 |
| Oct 02, 2026 | 8.49 | 8.61 | 8.02 | 8.23 | 335683.0 |
| Oct 01, 2026 | 8.33 | 8.54 | 8.10 | 8.35 | 234219.0 |
| Sep 30, 2026 | 8.27 | 8.60 | 8.19 | 8.27 | 219107.0 |
| Sep 29, 2026 | 8.30 | 8.381 | 8.030 | 8.20 | 231059.0 |
| Sep 28, 2026 | 7.86 | 8.55 | 7.789 | 8.32 | 362953.0 |
| Sep 25, 2026 | 7.85 | 8.00 | 7.44 | 7.94 | 236354.0 |
| Sep 24, 2026 | 7.57 | 7.89 | 7.43 | 7.83 | 209248.0 |
| Sep 23, 2026 | 7.70 | 7.75 | 7.34 | 7.56 | 174141.0 |
| Sep 22, 2026 | 7.34 | 7.80 | 7.30 | 7.78 | 312078.0 |
| Sep 21, 2026 | 6.86 | 7.35 | 6.825 | 7.26 | 281821.0 |
| Sep 18, 2026 | 6.85 | 6.94 | 6.755 | 6.85 | 194956.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.77 |
| Alnylam Pharmaceuticals, Inc. | 223.79 |
| Anika Therapeutics, Inc. | 21.09 |
| Savara, Inc. | 4.22 |
| Vericel Corp. | 42.57 |
Price Related Metrics
| PEG Ratio | -3.435 |
| Price to Book Value | 11.84 |
| Earnings Yield | -8.48% |
| Market Cap | 454.05M |
| PEGY Ratio | -3.435 |